Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1975-02-19
1976-11-16
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
260112R, 260112B, 424 78, 424 86, 424 89, 424 93, G01N 3102, G01N 3106, A61K 3912, A61K 3942
Patent
active
039925170
ABSTRACT:
A diagnostic composition for the detection of hepatitis B surface antigen in blood serum which comprises an aqueous suspension of finely divided synthetic resin particles of substantially uniform size coated with purified antibody specific to hepatitis B surface antigen is employed in a differentiating method where rheumatoid factor, which may cause nonspecific reactions, is absorbed with latex beads coated with human gamma globulin.
REFERENCES:
patent: 3838144 (1974-09-01), Leach
leach, British Med. J., 4, Dec. 1971, pp. 597-598.
Cayzer, The Lancet, May 18, 1974, pp. 947-949.
Fritz, J. of Immunology, vol. 108, Jan. 19, 1972, pp. 108-111.
Juji, Japan J. Exptl. Med., vol. 39, 1969, pp. 615-620.
Malin, Nature New Biol., vol. 235, Feb. 9, 1972, p. 182.
Dandliker, Biochemistry, vol. 6, No. 5, 1967, pp. 1460-1466.
Desmyter, Chem. Abs., vol. 79, 1973, pp. 287.
Horvath Bela Z.
Lowke George E.
Fagelson A. P.
Meyers Albert T.
Pfizer Inc.
LandOfFree
Detection of hepatitis B surface antigen by latex agglutination does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of hepatitis B surface antigen by latex agglutination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of hepatitis B surface antigen by latex agglutination will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-671338